MRES (Institute of Biomedical Research) EBITDA Margin %: 0.00% (As of Dec. 2010)


What is Institute of Biomedical Research EBITDA Margin %?

Institute of Biomedical Research MRES EBITDA Margin % is 0.00% as of Dec. 2010.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Institute of Biomedical Research's EBITDA for the three months ended in Dec. 2010 was $-0.01 Mil. Institute of Biomedical Research's Revenue for the three months ended in Dec. 2010 was $0.00 Mil. Therefore, Institute of Biomedical Research's EBITDA margin for the quarter that ended in Dec. 2010 was 0.00%.

Institute of Biomedical Research  (OTCPK:MRES) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Institute of Biomedical Research EBITDA Margin % Related Terms

Institute of Biomedical Research EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research EBITDA Margin % Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MRES vs HSTC, NTRR, VITIF: EBITDA Margin % Comparison

For the Biotechnology subindustry, Institute of Biomedical Research's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Institute of Biomedical Research EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Institute of Biomedical Research's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Institute of Biomedical Research's EBITDA Margin % falls into.


Institute of Biomedical Research EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Institute of Biomedical Research's EBITDA Margin % for the fiscal year that ended in Mar. 2010 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2010 )/Revenue (A: Mar. 2010 )
=-0.239/0
= %

Institute of Biomedical Research's EBITDA Margin % for the quarter that ended in Dec. 2010 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2010 )/Revenue (Q: Dec. 2010 )
=-0.005/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Institute of Biomedical Research (MRES) has a EBITDA Margin % of 0.00% as of Dec. 2010. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's EBITDA Margin % too high?
Institute of Biomedical Research's current EBITDA Margin % is 0.00%.
How does Institute of Biomedical Research's EBITDA Margin % compare to HSTC and NTRR?
Institute of Biomedical Research's EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current EBITDA Margin % is 0.00% as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.